如何治疗自身免疫性溶血性贫血
本文综述自身免疫性溶血性贫血(AIHA)的诊断与治疗困境,通过四个临床案例展示不同临床表现及诊疗路径,回顾诊断检测中的预后参数,并提供诊断与治疗流程,旨在为个体化治疗提供指导,并涉及检测阴性疑似AIHA的诊断。
要点
- AIHA诊断、预后和治疗存在困难,因溶血率和相关疾病差异大且临床异质性显著。
- 缺乏临床试验来优化和更新标准化循证治疗方法。
- 本文提供四个案例展示不同诊疗路径,并回顾诊断检测中的预后参数。
核心结论
- 本文旨在为AIHA的个体化治疗提供指导,通过案例和流程帮助临床医生管理不同情况下的AIHA患者。
研究设计与样本
- 本文为综述,基于临床实践中的四个案例和诊断检测参数回顾,提供诊断和治疗流程。
主要发现
- AIHA因溶血率和相关疾病差异大及临床异质性显著,诊断、预后和治疗存在困境。
- 缺乏临床试验来优化和更新标准化循证治疗方法。
- 本文通过四个案例展示不同临床表现及诊疗路径。
- 回顾了诊断检测中的预后参数。
- 提供了不同情况下的诊断和治疗流程。
临床怎么用
- 本文呈现了作者临床实践中使用的诊断和治疗路径,供临床医生参考。
- 作者希望本综述能为个体化治疗建议提供指导。
- 包含检测阴性疑似AIHA的诊断部分,以协助整体评估。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Autoimmune hemolytic anemia (AIHA) is an uncommon entity that presents diagnostic, prognostic, and therapeutic dilemmas despite being a well-recognized entity for over 150 years. This is because of significant differences in the rates of hemolysis and associated diseases and because there is considerable clinical heterogeneity. In addition, there is a lack of clinical trials required to refine and update standardized and evidence-based therapeutic approaches. To aid the clinician in AIHA management, we present four vignettes that represent and highlight distinct clinical presentations with separate diagnostic and therapeutic pathways that we use in our clinical practice setting. We also review the parameters present in diagnostic testing that allow for prognostic insight and present algorithms for both diagnosis and treatment of the AIHA patient in diverse situations. This is done in the hope that this review may offer guidance in regard to personalized therapy recommendations. A section is included for the diagnosis of suspected AIHA with negative test results, a relatively infrequent but challenging situation, in order to assist in the overall evaluation spectrum for these patients.
引用
- Go RS, Winters JL, Kay NE, et al. How I treat autoimmune hemolytic anemia. Blood. 2017. PMID: 28360039. doi:10.1182/blood-2016-11-693689
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。